You are here: Industry Insights > IQVIA

News List

Risk for Diabetes Increased for Pediatric Patients With COVID-19 drugs.com
January 21, 2022
Patients aged younger than 18 years with diagnosed COVID-19 have an increased...
IQVIA announces JAPAC expansion of IQVIA Biotech expresspharma
May 26, 2021
IQVIA announced the Japan and Asia Pacific (JAPAC) expansion of IQVIA Biotech, a tailored approach to deliver integrated clinical and commercial solutions for biotech and emerging biopharma companies, a company release said.
IQVIA report forecasts global medicine spending to hit $1.6 trillion in 2025 pharmatimes
May 06, 2021
A new report looking at global medicine spending and usage trends has forecasted growth for the global medicine market through 2025, noting a ‘modest’ impact on pre-pandemic drivers of medicine use and spending from COVID-19.
Moleculin Selects IQVIA Biotech to Advance COVID Treatment contractpharma
April 08, 2021
IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials expresspharma
January 04, 2021
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the subsequent learnings in clinical research/trials, emerging trends in this arena and more, in an interaction with Viveka Roychowdhury.
IQVIA and JDRF collaborate to improve understanding of Type 1 Diabetes using real world data expresspharma
July 24, 2020
The collaboration will pave the way for development of a real world research platform to facilitate evidence generation in type 1 diabetes for multiple stakeholders.
IQVIA Partners with AstraZeneca contractpharma
July 17, 2020
IQVIA has announced a collaboration with AstraZeneca to accelerate development of a potential new vaccine for COVID-19.
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate expresspharma
July 16, 2020
The collaboration is part of the US government’s Operation Warp Speed to accelerate the development of COVID-19 vaccines and treatments.
BC Platforms Closes $15 Million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics b3cnewswire
December 25, 2019
BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™.
BC Platforms partners with IQVIA to Extend Data Analytics in Genomics biospectrumasia
December 18, 2019
BC Platforms, a world leader in genomic data management and analytics, today announced that it has closed a USD $15 million financing round alongside a new commercial collaboration with IQVIA™.

Previous page 1 2 Next page